Carlos Claudio-Rodriguez, MD
Nephrology · Juana Diaz, PRNPI 1841524196
Payments from drug & device makers
Across 48 payments — averaging $52.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$2K
- Abbott$144
- Octapharma USA, Inc.$102
- GSK$96
- Mallinckrodt Hospital Products Inc.$93
- BD$83
- plus $347 from 11 others
What the payments were for
- Travel & lodging$1,41956%
- Food & beverage$1,11944%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 10 | $1,673 |
| Abbott | 10 | $144 |
| Octapharma USA, Inc. | 1 | $102 |
| GSK | 5 | $96 |
| Mallinckrodt Hospital Products Inc. | 3 | $93 |
| BD | 1 | $83 |
| Amgen | 4 | $61 |
| Bayer | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| AstraZeneca | 2 | $45 |
| Novartis | 2 | $30 |
| Shire North American Group Inc | 1 | $22 |
| Medtronic | 1 | $19 |
| Amicus Therapeutics, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Fresenius USA Marketing, Inc. | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclose Maven Catheter$1,409
- OCTAPLAS$102
How this compares
$2,538 in reported general payments places this provider in the 60th percentile of 161 nephrology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $33,386 |
| Mupirocin | 86 | $818 |
| Chlorhexidine Gluconate | 45 | $448 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Juana Diaz
- Eddie Rodriguez CastroToa Baja$591K
- Rafael Burgos CalderonBayamon$394K
- Eugenia Galindo RamosCaguas$360K
- Jose Cangiano-RiveraSan Juan$300K
- Ileana Ocasio MelendezDorado$261K
- William Hurtado-SantiagoMayaguez$250K
- Jacobo Loyola-TorresCaguas$145K
- Ricardo Calderon OrtizCaguas$97K
- Luis QuesadaSanturce$83K
- Jose Santiago SantiagoSan Juan$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.